“McCaffrey is currently performing a user-acceptance test on placebo products in cartons and blister packs as part of a pilot program ADT developed for Cephalon Inc. (Frazer, PA), an international biopharmaceuticals company. The pilot program was designed to provide end-to-end visibility for tracking branded pharmaceuticals throughout the supply chain. Cephalon is currently using bar code technology, but it is making the switch to RFID to track the movement of its products, manage inventories, and protect patient safety as well as product integrity. RFID also helps the company meet the tagging requirements of FDA and major wholesalers, like Wal-Mart, that are pushing the RFID trend.”
You are here: